natgillin/translations-raw huggingface dataset:
Stalevo 100 mg/25 mg/200 mg filmovertrukne tabletter levodopa/carbidopa/entacapon
Stalevo 100 mg/25 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Stalevo 100 mg/25 mg/200 mg filmovertrukne tabletter.
Stalevo 100 mg/25 mg/200 mg film-coated tablets
Stalevo 100 mg/25 mg/200 mg: Brun- eller grårøde, ovale filmovertrukne tabletter uden delekærv mærket med ”LCE 100” på den ene side.
Stalevo 100 mg/25 mg/200 mg: brownish or greyish red, oval, unscored film-coated tablets marked with ‘LCE 100’ on one side.
Stalevo 125 mg/31,25 mg/200 mg filmovertrukne tabletter
Stalevo 125 mg/31.25 mg/200 mg film-coated tablets
Stalevo 125 mg/31,25 mg/200 mg filmovertrukne tabletter.
Stalevo 125 mg/31.25 mg/200 mg film-coated tablets
Stalevo 125 mg/31,25 mg/200 mg: Lyse brunrøde, ovale, filmovertrukne tabletter mærket med ”LCE 125” på den ene side.
Stalevo 125 mg/31.25 mg/200 mg: light brownish red, oval film-coated tablets marked with ‘LCE 125’ on one side.
Stalevo 150 mg/37,5 mg /200 mg: Brun- eller grårøde, aflange, ellipse-formede filmovertrukne tabletter uden delekærv mærket ”LCE 150” på den ene side.
Stalevo 150 mg/37.5 mg/200 mg: brownish or greyish red, elongated-ellipse shaped, unscored film- coated tablets marked with ‘LCE 150’ on one side.
Stalevo 150 mg/37,5 mg/200 mg filmovertrukne tabletter
Stalevo 150 mg/37.5 mg/200 mg film-coated tablets
Stalevo 150 mg/37,5 mg/200 mg filmovertrukne tabletter levodopa/carbidopa/entacapon
Stalevo 150 mg/37.5 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Stalevo 150 mg/37,5 mg/200 mg filmovertrukne tabletter.
Stalevo 150 mg/37.5 mg/200 mg film-coated tablets
Stalevo 175 mg/43,75 mg/200 mg filmovertrukne tabletter
Stalevo 175 mg/43.75 mg/200 mg film-coated tablets
Stalevo 175 mg/43,75 mg/200 mg filmovertrukne tabletter.
Stalevo 175 mg/43.75 mg/200 mg film-coated tablets
Stalevo 175 mg/43,75 mg/200 mg: Lyse brunrøde, ovale, filmovertrukne tabletter uden delekærv mærket med ”LCE 175” på den ene side.
Stalevo 175 mg/43.75 mg/200 mg: light brownish red, oval, unscored film-coated tablets marked with ‘LCE 175’ on one side.
Stalevo 200 mg/50 mg/200 mg filmovertrukne tabletter
Stalevo 200 mg/50 mg/200 mg film-coated tablets
Stalevo 200 mg/50 mg/200 mg filmovertrukne tabletter levodopa/carbidopa/entacapon
Stalevo 200 mg/50 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Stalevo 200 mg/50 mg/200 mg filmovertrukne tabletter.
Stalevo 200 mg/50 mg/200 mg film-coated tablets
Stalevo 200 mg/50 mg/200 mg tabletter: Mørk brunrøde, ovale filmovertrukne tabletter uden delekærv mærket med ”LCE 200” på den ene side.
Stalevo 200 mg/50 mg/200 mg: dark brownish red, oval, unscored film-coated tablets marked with ‘LCE 200’ on one side.
Stalevo 50 mg/12,5 mg/200 mg filmovertrukne tabletter
Stalevo 50 mg/12.5 mg/200 mg film-coated tablets
Stalevo 50 mg/12,5 mg/200 mg filmovertrukne tabletter levodopa/carbidopa/entacapon
Stalevo 50 mg/12.5 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Stalevo 50 mg/12,5 mg/200 mg filmovertrukne tabletter.
Stalevo 50 mg/12.5 mg/200 mg film-coated tablets
Stalevo 50 mg/12,5 mg/200 mg: Brun- eller grårøde, runde, hvælvede filmovertrukne tabletter uden delekærv mærket med ”LCE 50” på den ene side.
Stalevo 50 mg/12.5 mg/200 mg: brownish or greyish red, round, convex unscored film-coated tablets marked with ‘LCE 50’ on one side.
Stalevo 75 mg/18,75 mg/200 mg filmovertrukne tabletter levodopa/carbidopa/entacapon
Stalevo 75 mg/18.75 mg/200 mg film-coated tablets levodopa/carbidopa/entacapone
Stalevo 75 mg/18,75 mg/200 mg filmovertrukne tabletter.
Stalevo 75 mg/18.75 mg/200 mg film-coated tablets
Stalevo 75 mg/18,75 mg/200 mg: Lyse brunrøde, ovale, filmovertrukne tabletter mærket med ”LCE 75” på den ene side.
Stalevo 75 mg/18.75 mg/200 mg: light brownish red, oval film-coated tablets marked with ‘LCE 75’ on one side.
Stalevo anvendes hos patienter, der behandles med en kombination af levodopa og en dopa-decarboxylasehæmmer (to standardlægemidler mod Parkinsons sygdom), hos hvem der hen mod slutningen af perioden mellem to doser af medicinen kommer "fluktuationer".
Stalevo is used in patients who are being treated with a combination of levodopa and an inhibitor of dopa decarboxylase (two standard treatments for Parkinson’s disease) but are having ‘fluctuations’ towards the end of the period between two doses of their medication.
Stalevo bruges til behandling af Parkinsons sygdom.
Stalevo is used for the treatment of Parkinson’s disease.
Stalevo bør administreres med forsigtighed til patienter med iskæmisk hjertesygdom, alvorlig kardiovaskulær - eller pulmonal sygdom, asthma bronchiale, nyresygdomme eller endokrine sygdomme eller ulcus pepticum eller kramper i anamnesen.
Stalevo therapy should be administered cautiously to patients with ischemic heart disease, severe cardiovascular or pulmonary disease, bronchial asthma, renal or endocrine disease, history of peptic ulcer disease or history of convulsions.
Stalevo bør administreres med forsigtighed til patienter med iskæmisk hjertesygdom, alvorlig kardiovaskulær eller pulmonal sygdom, asthma bronchiale, nyresygdomme eller endokrine sygdomme eller ulcus pepticum eller kramper i anamnesen.
Stalevo therapy should be administered cautiously to patients with ischemic heart disease, severe cardiovascular or pulmonary disease, bronchial asthma, renal or endocrine disease, history of peptic ulcer disease or history of convulsions.
Stalevo er ikke egnet til behandling af lægemiddelinducerede ekstrapyramidale reaktioner.
Stalevo is not recommended for the treatment of drug-induced extrapyramidal reactions
Stalevo er indiceret til behandling af voksne patienter med Parkinsons sygdom og motoriske end-of- dose fluktuationer, som ikke kan stabiliseres på behandling med levodopa/dopa-decarboxylase (DDC) hæmmere.
Stalevo is indicated for the treatment of adult patients with Parkinson’s disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.
Stalevo findes i seks forskellige pakningsstørrelser (10, 30, 100, 130, 175 og 250 tabletter).
Stalevo comes in six different pack sizes (10, 30, 100, 130, 175 or 250 tablets).
Stalevo indeholder saccharose, og bør ikke anvendes til patienter med arvelig fructoseintolerans, glucose/galactosemalabsorption og sucrase-isomaltasemangel.
Stalevo contains sucrose, and therefore patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Stalevo indeholder tre virksomme stoffer (levadopa, carbidopa, entacapon) i en filmovertrukket tablet.
Stalevo contains three active substances (levodopa, carbidopa and entacapone) in one film-coated tablet.
Stalevo indeholder tre virksomme stoffer (levodopa, carbidopa, entacapon) i en filmovertrukken tablet.
Stalevo contains three active substances (levodopa, carbidopa and entacapone) in one film-coated tablet.
Stalevo indeholder tre virksomme stoffer (levodopa, carbidopa, entacapon) i én filmovertrukket tablet.
Stalevo contains three active substances (levodopa, carbidopa and entacapone) in one film-coated tablet.
Stalevo kan inducere ortostatisk hypotension.
Stalevo may induce orthostatic hypotension.
Stalevo må ikke anvendes hos patienter med:
Stalevo must not be used in patients with:
Stalevo må ikke anvendes samme med anden medicin af typen MAO-hæmmere (en type antidepressiver, der hæmmer enzymet monoaminoxidase).
Stalevo must not be used together with other medicines that belong to the group ‘monoamine oxidase inhibitors’ (a type of antidepressant).
Stamcellerne går bagefter tilbage ind i knoglemarven og producerer blodceller.
The stem cells will then go back into the bone marrow and produce blood cells;
Stammer 2016/2017
Strains 2015/2016
Stammer 2016/2017
Strains 2016/2017
stammer af inaktiveret Influenza A virus/svin*
strains of inactivated Influenza A virus/swine
Stammer af inaktiveret Influenza A virus/svin/ Bakum/IDT1769/2003 (H3N2) ≥ 10,53 log2 GMNU
Strains of inactivated Influenza A virus/swine/ Bakum/IDT1769/2003 (H3N2) ≥ 10.53 log2 GMNU
Stammer af inaktiveret Influenza A virus/svin/ Bakum/IDT1769/2003 (H3N2) ≥ 10,53 log2 GMNU
Strains of inactivated Influenza A virus/swine/ Bakum/IDT1769/2003 (H3N2) ≥ 10.53 log2 GMNU,
Stammer Aldersspænd
Strains Age range
Stammer med match af antigener
Antigenically Matched Strains
Stammer med P[4]- genotype
Strains with P[4] genotype
Stammer med P[6]- genotype
Strains with P[6] genotype
Stammer med P[8]- genotype
Strains with P[8]
Stammer med P[8]- genotype
Strains with P[8] genotype
Stammer med P[8]-genotype
Strains with P[8] genotype
Stammerne af Leptospira- bakterier i Canigen L4 er inaktiveret (dræbt), så de ikke kan forårsage sygdom.
The strains of Leptospira bacteria in Canigen L4 are killed (inactivated) so that they do not cause disease.
Stammerne af Leptospira- bakterier i Versican Plus L4 er inaktiveret (dræbt), så de ikke kan forårsage sygdom.
The strains of Leptospira bacteria in Versican Plus L4 are killed (inactivated) so that they do not cause disease.
Stammespecifik
Strain-specific
Stammespecifikt anti-HA-antistof
Strain specific anti-HA antibody
stamopløsning til radioaktive lægemidler.
Radiopharmaceutical precursor, solution.
Standard - fremstilling (rekonstitueret Caspofungin Accord overført til 250 ml) endelig koncentration
Standard preparation (reconstituted Caspofungin Accord added to 250 mL) final concentration
Standard hyperkalcæmirelaterede metabolske parametre som serumniveauer af calcium, fosfat og magnesium bør monitoreres grundigt efter påbegyndt behandling med Zoledronsyre Teva.
Standard hypercalcaemia-related metabolic parameters, such as serum levels of calcium, phosphate and magnesium, should be carefully monitored after initiating Zoledronic acid Teva therapy.
Standard hæmatologiske prøver og klinisk-kemiske blodundersøgelser (komplet blodtælling og differentialtælling, trombocyttal, elektrolytter, leverenzymer, serum-protein, serum-bilirubin og serum- kreatinin) bør udføres hos alle patienter før og med faste intervaller under systemisk IntronA-behandling.
Standard haematological tests and blood chemistries (complete blood count and differential, platelet count, electrolytes, liver enzymes, serum protein, serum bilirubin and serum creatinine) are to be conducted in all patients prior to and periodically during systemic treatment with IntronA.
Standard hæmatologiske prøver og klinisk-kemiske blodundersøgelser (komplet blodtælling og differentialtælling, trombocyttal, elektrolytter, leverenzymer, serum-protein, serum-bilirubin og serum- kreatinin) bør udføres hos alle patienter før og med faste intervaller under systemisk Viraferon-behandling.
Standard haematological tests and blood chemistries (complete blood count and differential, platelet count, electrolytes, liver enzymes, serum protein, serum bilirubin and serum creatinine) are to be conducted in all patients prior to and periodically during systemic treatment with Viraferon.
Standard hæmatologiske tests og blodkemi (komplet blodtælling og differentialtælling, blodpladetal, elektrolytter, serumkreatinin, leverfunktionsundersøgelser, urinsyre) skal udføres hos alle patienter før påbegyndelse af behandling.
Standard haematologic tests and blood chemistries (complete blood count [CBC] and differential, platelet count, electrolytes, serum creatinine, liver function tests, uric acid) must be conducted in all patients prior to initiating therapy.
Standard onkologi praksis for behandling af neutropeni er enten at administrere topotecan sammen med anden medicin (f.eks.
Standard oncology practice for the management of neutropenia is either to administer topotecan with other medicinal products (e.g.
Standard onkologi praksis for behandling af neutropeni, er enten at administrere topotecan sammen med anden medicin (f.eks.
Standard oncology practice for the management of neutropenia is either to administer topotecan with other medicinal products (e.g.
Standard onkologik praksis for behandling af neutropeni er enten at administrere topotecan sammen med anden medicin (f.eks.
Standard oncology practice for the management of neutropenia is either to administer topotecan with other medicinal products (e.g.
Standard onkologik praksis for behandling af neutropeni, er enten at administrere topotecan sammen med anden medicin (f.eks.
Standard oncology practice for the management of neutropenia is either to administer topotecan with other medicinal products (e.g.
Standard onkologisk praksis for behandling af neutropeni er enten at administrere topotecan sammen med anden medicin (f.eks.
Standard oncology practice for the management of neutropenia is either to administer topotecan with other medications (e.g.
Standard onkologisk praksis for behandling af neutropeni er enten at administrere topotecan sammen med anden medicin (f.eks.
Standard oncology practice for the management of neutropenia is either to administer topotecan with other medicinal products (e.g.
Standard vaccinationsprogrammet for primær vaccination med Twinrix Pædiatrisk består af tre doser, den første administreres på en udvalgt dato, den anden en måned senere og den tredje seks måneder efter den første dosis.
The standard primary course of vaccination with Twinrix Paediatric consists of three doses, the first administered at the elected date, the second one month later and the third six months after the first dose.
Standard- terapi (N= 406)
Standard therapy (N= 406)
Standard-dosis 40/20 mg hver anden uge
Standard Dose 40/20 mg eow
Standard-fremstilling (rekonstitueret Cancidas overført til 250 ml) endelig koncentration
Standard preparation (reconstituted CANCIDAS added to 250 ml) final concentration
Standardbehandling
Standard therapy
Standardbehandling (n=42)
SOC (n=42)
Standardbehandlingen bestod i primær kirurgisk excision og/eller ikke-kirurgisk débridement med topikale lægemidler, der inducerer maceration og autolyse af sårskorpen i henhold til standardpraksis for hvert studiecenter.
Standard of care consisted of primary surgical excision and/or nonsurgical debridement using topical medicinal products to induce maceration and autolysis of eschar according to each study site’s standard practice.
Standardbehandlingen omfattede kortikosteroider (96 %, hvoraf 69 % fik en dosis på > 7,5 mg/dag), immunsuppressiva (42 %) og malariamidler (67 %).
Background medicinal products included corticosteroids (96%; >7.5 mg/day 69%), immunosuppressives (42%), and anti-malarials (67%).
Standardblisterkort (med sol/måne-symbol) i æsker med 60 og 180 tabletter
tandard blisters (with sun/moon symbols) in cartons of 60 and 180 tablets
Standardblodundersøgelser vil blive taget for at tjekke dit blod samt nyre- og leverfunktion.
Standard blood tests will be taken to check your blood, kidney and liver function.
Standarddosen af den orale suspension er 0,5 ml pr. kg legemsvægt.
The standard dose of the oral suspension is 0.5 ml per kg bodyweight.
Standarddoser af voriconazol
Medicinal product
Standarddosering af 5- HT3-antagonister.
Standard dose of 5-HT3 antagonists.
Standarddosering af 5-HT3- antagonister.
Standard dose of 5-HT3 antagonists.
Standarddoserne af NRTI’ere, givet hver 12. time, blev anvendt i hver af disse studier.
The standard doses of NRTIs given every 12 hours were used in each of these studies.
Standarddoserne af NRTI’ere, givet hver 12. time, blev anvendt i hvert af disse studier.
The standard doses of NRTIs given every 12 hours were used in each of these studies.
Standarddosis
For the oral
Standarddosis af Clopidogrel Krka er en 75 mg tablet en gang dagligt med eller uden et måltid.
The standard dose of Clopidogrel Krka is one 75 mg tablet once a day, taken with or without food.
Standarddosis af Clopidogrel Qualimed er én 75 mg -tablet én gang dagligt med eller uden et måltid.
The standard dose of Clopidogrel Qualimed is one 75 mg tablet once a day, taken with or without food.
Standarddosis af Clopidogrel TAD er en 75 mg tablet en gang dagligt med eller uden et måltid.
The standard dose of Clopidogrel TAD is one 75 mg tablet once a day, taken with or without food.
Standarddosis af Clopidogrel Teva Generics B.V. er én 75 mg tablet én gang om dagen, som tages med eller uden mad.
The standard dose of Clopidogrel Teva Generics B.V. is one 75-mg tablet once a day, taken with or without food.
Standarddosis af Clopidogrel Teva Pharma B.V. er en 75-mg tablet en gang dagligt taget med eller uden et måltid.
The standard dose of Clopidogrel Teva Pharma B.V. is one 75-mg tablet once a day, taken with or without food.
Standarddosis af Clopidogrel Teva Pharma er en 75 mg-tablet en gang dagligt.
The standard dose of Clopidogrel Teva Pharma is one 75-mg tablet once a day.
Standarddosis af Cystadane til patienter over 10 år er 6 g dagligt, fordelt på to lige store doser.
The standard dose of Cystadane for patients aged over 10 years is 6 g a day, divided into two equal doses.
Standarddosis er 800 mg hver ottende time.
The standard dose is 800 mg every eight hours.
Standarddosis på 60 – 75 mg/m2
Standard dose of 60 - 75mg/m2
Standardforholdsregler for at forebygge infektioner, som skyldes brugen af lægemidler fremstillet af humant blod eller plasma, omfatter udvælgelse af donorer, screening af de enkelte bloddonationer og plasma-pools for specifikke infektionsmarkører samt anvendelse af effektive foranstaltninger under produktionen for at inaktivere/fjerne vira.
Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses.
Standardforholdsregler til at forhindre, at infektioner overføres fra lægemidler, som er fremstillet ud fra humant blod eller plasma, omfatter selektion af donorer, screening af enkeltdonationer og plasmapools for specifikke markører for infektion samt indførelse af effektive trin til inaktivering/ eliminering af virus under fremstillingsprocessen.
Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses.
Standardforholdsregler til forebyggelse af infektioner, der skyldes brug af lægemidler, der er fremstillet af humant blod eller plasma, omfatter udvælgelse af donorer, screening af enkeltdonationer og plasmapools for specifikke infektionsmarkører samt inkludering af effektive trin til inaktivering/fjernelse af vira som en del af fremstillingsproceduren.
Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses.
Standardforholdsregler, som skal forhindre, at infektioner overføres fra lægemidler, der er fremstillet af humant blod eller plasma, omfatter udvælgelse af donorer, screening af de enkelte donationer og plasmapools for specifikke infektionsmarkører, samt at effektive fremstillingstrin for inaktivering/eliminering af virus er en del af fremstillingsprocessen.
Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of virus.
Standardpakningen for en måned indeholder 56 x 30 mg tabletter.
The one-month standard pack contains 56 x 30 mg tablets.
Standardpakningen for tre måneder indeholder 168 x 30 mg tabletter.
The three-month standard pack contains 168 x 30 mg tablets.
Standardrisiko
Standard risk
Stands behandlingen og kontakt øjeblikkeligt din læge, hvis du, efter du har givet dit barn HEMANGIOL, observerer følgende symptomer, som kan være tegn på bronchospasme (kortvarig restriktion af bronkierne, der fører til åndedrætsbesvær): hoste, hurtig eller besværet vejrtrækning eller hiven efter vejret, associeret eller ikke med en blålig hud.
Stop treatment and contact your doctor immediately if after giving HEMANGIOL to your child you observe the following symptoms suggestive of a bronchospasm (temporary restriction of the bronchial tubes that leads to difficulty breathing): cough, quick or difficult breathing or wheezing, associated or not with a bluish-coloured skin:.
Stands ikke behandlingen ved det første tegn på bedring.
Do not stop treatment at the first sign of improvement.
Stannochloriddihydrat 50 mikrogram (essentielt hjælpestof) Natrium -D-glucoheptonatdihydrat
Stannous chloride dihydrate 50 micrograms (essential excipient) Sodium -D-glucoheptonate dihydrate
Stapfylococcus spp.
Staphylococcus spp.
Staphylococci udledt af følsomhedsgrænsen for methicillin
Staphylococci inferred from the methicillin breakpoint
Staphylococcus aureus (CP8) stamme SP 140 inaktiveret, der udtrykker slime associated antigenic complex (SAAC)................................................................................................ > 50 RED80 **
Staphylococcus aureus (CP8) strain SP 140 inactivated, expressing slime associated antigenic complex (SAAC)................................................................................................................ > 50 RED80
Staphylococcus aureus (CP8) stamme SP 140 inaktiveret, der udtrykkerslime associated antigenic complex (SAAC).................................................................................................> 50 RED80 **
Staphylococcus aureus (CP8) strain SP 140 inactivated, expressing slime associated antigenic complex (SAAC) .............…………………………………………… > 50 RED80
Staphylococcus aureus (inklusive methicillin-resistente stammer)
Staphylococcus aureus (including methicillin-resistant strains)
Staphylococcus aureus (kun methicillin-følsomme stammer)
Staphylococcus aureus (methicillin-susceptible strains only)
Staphylococcus aureus (kun methicillinfølsomme stammer)*^ Staphylococcus spp. (kun methicillinfølsomme stammer)^ Streptococcus pneumoniae*
Staphylococcus aureus (methicillin susceptible strains only)*^ Staphylococcus spp. (methicillin susceptible strains only)^ Streptococcus pneumoniae
Staphylococcus aureus (methicillin-følsom og methicillin-resistent)
Staphylococcus aureus (methicillin-susceptible and methicillin-reistant)
Staphylococcus aureus methicillin følsomme (MSSA)*
Staphylococcus aureus methicillin susceptible (MSSA)
Staphylococcus aureus methicillin resistente (MRSA)+
Staphylococcus aureus methicillin resistant (MRSA)+
Staphylococcus aureus*$
Staphylococcus aureus* $
Staphylococcus pseudintermedius samt Malassezia pachydermatis.
Staphylococcus pseudintermedius and Malassezia pachydermatis.
Staphylococcus spp: Følsom ≤ 0,125 mg/l; resistent > 0,125 mg/l,
Staphylococcus spp.: Susceptible ≤ 0.125 mg/l; Resistant > 0.125 mg/l,
Starlix 120 mg filmovertrukne tabletter Nateglinid
Starlix 120 mg film-coated tablets Nateglinide
Starlix 120 mg tabletter Nateglinid
Starlix 120 mg tablets Nateglinide
Starlix 180 mg filmovertrukne tabletter Nateglinid
Starlix 180 mg film-coated tablets Nateglinide
Starlix 180 mg tabletter Nateglinid
Starlix 180 mg tablets Nateglinide
Starlix 60 mg filmovertrukne tabletter Nateglinid
Starlix 60 mg film-coated tablets Nateglinide
Starlix 60 mg filmovertrukne tabletter Starlix 120 mg filmovertrukne tabletter Starlix 180 mg filmovertrukne tabletter Nateglinid
Starlix 60 mg film-coated tablets Starlix 120 mg film-coated tablets Starlix 180 mg film-coated tablets Nateglinide
Starlix 60 mg filovertrukne tabletter er lyserøde, runde tabletter med ”STARLIX” indprintet på én side og ”60” på den anden.
Starlix 60 mg film-coated tablets are pink, round tablets with “STARLIX” marked on one side and “60” on the other.
Starlix 60 mg tabletter Nateglinid
Starlix 60 mg tablets Nateglinide
Starlix bruges til behandling af type 2-diabetes.
Starlix is used to treat patients with type 2 diabetes.